 All links are HDMA members-only content. Join today. |
Food and Drug Administration (FDA):
- HDMA Comments to FDA on their Drug Shortages Task Force - March 14, 2013
- HDMA Comments to FDA on Scheduling of Hydrocodone-Combination Products - February 1, 2013
- HDMA Comments to FDA on Proposed UDI Rule - November 7, 2012
- HDMA Comments to FDA on Conditions of Safe Use to Expand Certain Prescription Drugs for Non-Prescription Use - May 7, 2012
- HDMA's Statement to FDA on Approving Certain Prescription Drugs as OTC under Conditions of Safe Use - March 23, 2012
- HDMA's Comments to FDA on Establishing Timeframes for Implementation of Labeling Changes - February 17, 2012
- HDMA Comments to FDA on Information Collection for MedGuides - February 8, 2012
- HDMA Comments to FDA on Retrospective Review of the Bar Code Rule - January 6, 2012
- HDMA Comments to FDA on Transparency Initiative - November 30, 2011
- HDMA Statement to FDA's Joint Advisory Committee Meeting on REMS - December 1, 2011
More FDA comments here
Drug Enforcement Administration (DEA):
More DEA comments here
Department of Justice (DOJ):
Office of Management and Budget (OMB):
Environmental Protection Agency (EPA):
Consumer for Product Safety and Commission (CPSC):
Centers for Medicare and Medicaid Services (CMS):
Department of Defense (DOD):
Office of Labor-Management Standards (OLMS):
Occupational Safety and Health Administration (OSHA):
Department of Transportation (DOT):
The National Labor Relations Board (NLRB):
United States Pharmacopeia (USP):
Contacts
Anita Ducca
Vice President, Regulatory Affairs
703-885-0240
aducca@hdmanet.org
|
